Zhengwu Sun (Former)
1 – 5 of 10
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation
(
- Contribution to journal › Article
- 2006
-
Mark
Pancreatitis-associated pulmonary injury - effects of Lexipafant, a PAF-antagonist
(
- Contribution to journal › Article
- 2005
-
Mark
Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
(
- Contribution to journal › Article
- 2002
-
Mark
Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
(
- Contribution to journal › Article
-
Mark
Gut barrier permeability, reticuloendothelial system function and protease inhibitor levels following intestinal ischaemia and reperfusion--effects of pretreatment with N-acetyl-L-cysteine and indomethacin.
(
- Contribution to journal › Article